Brian Woods

Brian Woods

Auto-generated profile, based on publicly available information

Brian Woods

Division of Immunology, Boston Children’s Hospital, Harvard Medical School, MA (B.W., J.C., R.S.G.).

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
EFEvgenij Fiskin
Evgenij Fiskin
GEGökcen Eraslan
Gökcen Eraslan
MAMaria Beatrice Alora-Palli
Maria Beatrice Alora-Palli
JLJuan Manuel Leyva-Castillo
Juan Manuel Leyva-Castillo
SKSean Kim
Sean Kim
RXRamnik J Xavier
Ramnik J Xavier
In healthy skin, a cutaneous immune system maintains the balance between tolerance towards innocuous environmental antigens and immune responses against pathological agents. In atopic dermatitis (AD), barrier and immune dysfunction result in chronic tissue inflammation. Our understanding of the skin tissue ecosystem in AD remains incomplete with regard to the hallmarks of pathological barrier formation, and cellular state and clonal composition of disease-promoting cells. Here, we generated a multi-modal cell census of 310,691 cells spanning 86 cell subsets from whole skin tissue of 19 adult individuals, including non-lesional and lesional skin from 11 AD patients, and integrated it with 396,321 cells from four studies into a comprehensive human skin cell atlas in health and disease. Reconstruction of human keratinocyte differentiation from basal to cornified layers revealed a disrupted cornification trajectory in AD. This disrupted epithelial differentiation was associated with signals from a unique immune and stromal multicellular community comprised of MMP12 + dendritic cells (DCs), mature migratory DCs, cycling ILCs, NK cells, inflammatory CCL19 + IL4I1 + fibroblasts, and clonally expanded IL13 + IL22 + IL26 + T cells with overlapping type 2 and type 17 characteristics. Cell subsets within this immune and stromal multicellular community were connected by multiple inter-cellular positive feedback loops predicted to impact community assembly and maintenance. AD GWAS gene expression was enriched both in disrupted cornified keratinocytes and in cell subsets from the lesional immune and stromal multicellular community including IL13 + IL22 + IL26 + T cells and ILCs, suggesting that epithelial or immune dysfunction in the context of the observed cellular communication network can initiate and then converge towards AD. Our work highlights specific, disease-associated cell subsets and interactions as potential targets in progression and resolution of chronic inflammation.

1 October 2026 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
GPGrigorios Panteloglou
Grigorios Panteloglou
PZPaolo Zanoni
Paolo Zanoni
CLChristopher S. Law
Christopher S. Law
BWBrian Woods
Brian Woods
AOAlaa Othman
Alaa Othman
Arnold Von EckardsteinArnold Von Eckardstein
Arnold Von Eckardstein
BACKGROUND: Reverse cholesterol transport by HDLs (high-density lipoproteins) is considered an antiatherogenic metabolic pathway. Hepatocytes are the main contributors to the efficacy of this pathway by the production of apoA-I (apolipoprotein A1) and its lipidation by ABCA1 (ATP-binding cassette transporter A1), selective uptake of cholesterol via SR-BI (scavenger receptor class B type 1), and uptake of entire HDL particles. The molecular determinants of the latter step are not well understood. METHODS: We performed a genome-wide RNA interference screen for genes limiting the uptake of HDL fluorescently labeled at its protein moiety into Huh-7 hepatocarcinoma cells. Top hit genes were validated by targeted in vitro experiments and the analysis of associations between their variants and HDL-C (HDL-cholesterol) levels in the databases of the Global Lipids Genetics Consortium and the UK Biobank, as well as inborn errors of metabolism and their respective mouse models. RESULTS: The knockdown of 128 genes significantly inhibited HDL uptake. Six of them encode components of the COPI (coat protein I) coatomer, namely, COPA , COPB1 , COPB2 , COPG1 , ARCN1 , and COPZ1 . Knocking down any of them decreased the uptake of both fluorescently labeled proteins and lipids of HDL, the cell surface abundance of SR-BI, and APOA1 expression and apoA-I secretion but increased the cell surface abundance of ABCA1. Common single-nucleotide polymorphisms of ARCN1 and COPB1 were associated with significantly higher HDL-C levels in the population, while rare COPA and COPG1 variants causing immunopathies were associated with rather lower levels of HDL-C in both affected patients and the corresponding genetically modified mice. CONCLUSIONS: In hepatocytes, the COPI coatomer regulates HDL holoparticle uptake, selective lipid uptake, apoA-I secretion, and ABCA1 expression, and thereby, it influences plasma levels of HDL-C.

26 August 2025 in medRxiv
Verified
Preprint
Open access
PDF file
GPGrigorios Panteloglou
Grigorios Panteloglou
PZPaolo Zanoni
Paolo Zanoni
CLChristopher S. Law
Christopher S. Law
BWBrian Woods
Brian Woods
AOAlaa Othman
Alaa Othman
Arnold Von EckardsteinArnold Von Eckardstein
Arnold Von Eckardstein
Background: Reverse cholesterol transport by high density lipoproteins (HDL) is considered as an anti-atherogenic metabolic pathway. Hepatocytes determine the efficacy of this pathway by the production of apolipoprotein A-I (apoA-I) and its lipidation by ATP binding cassette transporter A1 (ABCA1), selective uptake of cholesterol via scavenger receptor BI (SR-BI) and uptake of entire HDL particles. The molecular determinants of the latter step are not well understood. Methods: We performed a genome-wide RNA interference screen for genes limiting the uptake of fluorescent HDL into Huh-7 hepatocarcinoma cells. Top hit genes were validated by targeted in vitro experiments and the analysis of associations between their variants and HDL cholesterol levels in the databases of the Global Lipids Genetics Consortium and UK Biobank as well as inborn errors of metabolism and their respective mouse models. Results: The knockdown of 128 genes significantly inhibited HDL uptake. Six of them encode for components of the COPI coatomer, namely COPA, COPB1, COPB2, COPG1, ARCN1, and COPZ1 . Knocking down any of them decreased the uptake of both fluorescently labeled proteins and lipids of HDL, the cell surface abundance of SR-BI as well as APOA1 expression and apoA-I secretion but increased the cell surface abundance of ABCA1 as well as cholesterol efflux. Single nucleotide polymorphisms of COPB1, ARCN1, and COPZ2 were associated with significantly higher HDL-cholesterol (HDL-C) levels in the population while rare COPA and COPG1 variants causing immunopathies in humans and mice were associated with low levels of HDL cholesterol. Conclusions: In hepatocytes, the COPI coatomer regulates HDL holoparticle uptake, selective lipid uptake, apoA-I secretion, and cholesterol efflux, and thereby, it influences plasma levels of HDL-C. Highlights: By genome-wide RNA interference screening and replication experiments we found six components of the COPI coatomer, namely COPA, COPB1, COPB2, COPG1, ARCN1, and COPZ1 to limit the uptake of HDL holoparticles into Huh-7 hepatocarcinoma cells, possibly by a mechanism that involves ATP binding cassette transporter ABCA1 Loss of any of expression of any of these six COPI genes decreases HDL lipid uptake by interfering with the glycosylation and cell surface abundance of scavenger receptor SR-BI Loss of any of expression of any of these six COPI genes decreases HDL secretion from Huh7 cells, possibly by decreasing gene expression of APOA1 and ABCA1, but despite increasing cell surface abundance of ABCA1 and ABCA1-mediated cholesterol efflux Single nucleotide polymorphisms of ARCN1 are associated with significantly higher HDL-cholesterol (HDL-C) levels in the population while rare COPA and COPG1 variants causing immunopathies in humans and mice were associated with rather low levels of HDL cholesterol.